Finance

Beta
Lists
ORX:STO
Orexo AB
18,00 SEK
-16,28%
(-3,50) 1D
16 հլս, 17:29:31 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ORX...
Open
19,58 SEK
High
19,88 SEK
Low
16,84 SEK
Mkt. cap
632,29 մլն
Avg. vol.
24,03 հզր
Volume
177,99 հզր
P/E ratio
0,71
52-wk high
43,40 SEK
52-wk low
16,84 SEK
EPS
25,33 SEK
Shares outstanding
35,13 մլն
No. of employees
65
Open
19,58 SEK
High
19,88 SEK
Low
16,84 SEK
Mkt. cap
632,29 մլն
Avg. vol.
24,03 հզր
Volume
177,99 հզր
P/E ratio
0,71
52-wk high
43,40 SEK
52-wk low
16,84 SEK
EPS
25,33 SEK
Shares outstanding
35,13 մլն
No. of employees
65
News stories
From sources across the web
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees65
Founded1995
Headquarters-
Sector-
Websiteorexo.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
118,20 մլն
118,70 մլն
3,30 մլն
5,00 մլն
Cost of goods sold
8,40 մլն
7,10 մլն
2,60 մլն
500,00 հզր
Cost of revenue
8,40 մլն
7,10 մլն
2,60 մլն
500,00 հզր
Research and development expenses
57,20 մլն
61,70 մլն
55,60 մլն
50,10 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
71,10 մլն
71,90 մլն
28,00 մլն
37,40 մլն
Operating expense
128,10 մլն
132,51 մլն
80,70 մլն
80,20 մլն
Total operating expenses
136,50 մլն
139,61 մլն
83,30 մլն
80,70 մլն
Operating income
-18,30 մլն
-20,91 մլն
-80,00 մլն
-75,70 մլն
Other non operating income
-500,00 հզր
-200,00 հզր
-200,00 հզր
-100,00 հզր
EBT including unusual items
-33,90 մլն
-32,70 մլն
-115,50 մլն
-104,20 մլն
EBT excluding unusual items
-34,50 մլն
-32,71 մլն
-93,50 մլն
-104,50 մլն
Income tax expense
5,90 մլն
-2,90 մլն
100,00 հզր
1,00 մլն
Effective tax rate
-17,40%
8,87%
-0,09%
-0,96%
Other operating expenses
-200,00 հզր
-1,09 մլն
-2,90 մլն
-7,30 մլն
Net income
-39,80 մլն
-29,80 մլն
724,80 մլն
-133,90 մլն
Net profit margin
-33,67%
-25,11%
21 963,64%
-2 678,00%
Earnings per share
-1,15
-
-
-
Interest and investment income
300,00 հզր
800,00 հզր
600,00 հզր
4,40 մլն
Interest expense
-12,00 մլն
-11,30 մլն
-12,20 մլն
-32,90 մլն
Net interest expenses
-11,70 մլն
-10,50 մլն
-11,60 մլն
-28,50 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,90 մլն
-9,61 մլն
-46,80 մլն
-66,90 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer